Scarica l'app Stockscreener
354.07
1.57%
5.47
Dopo l'orario di chiusura:
354.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$348.60
Aprire:
$348.49
Volume 24 ore:
462.24K
Relative Volume:
0.54
Capitalizzazione di mercato:
$24.92B
Reddito:
$3.22B
Utile/perdita netta:
$542.70M
Rapporto P/E:
47.33
EPS:
7.4805
Flusso di cassa netto:
$458.00M
1 W Prestazione:
+3.83%
1M Prestazione:
-0.56%
6M Prestazione:
+42.23%
1 anno Prestazione:
+47.20%
Intervallo 1D:
$347.37
$356.00
Intervallo di 1 settimana:
$342.78
$356.00
Portata 52W:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
354.07 | 23.31B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
378.81 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.86 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
71.81 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
211.94 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.23 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
WST Maintains Rating by Evercore ISI Group -- Price Target Raised to $425 - GuruFocus
WEST PHARMACEUTICAL SERVICES INC : EVERCORE ISI RAISES TARGET PRICE TO $425 FROM $410 - Bitget
BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating - marketscreener.com
Weiss Asset Management LP Invests $1.99 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical stock trades near record levels as injectable packaging demand supports growth - Ad-hoc-news.de
Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia - MarketBeat
West Pharmaceutical stock holds recent gains as investors weigh steady growth and guidance - AD HOC NEWS
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan - Yahoo Finance UK
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
ETFs Investing in West Pharmaceutical Services, Inc. Stocks - TradingView
West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST - TradingView
What Does Eric Green's Retirement Mean for West Pharmaceutical Services - Kavout | AI
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock trades steady as investors digest stronger 2025 guidance and recent margin - AD HOC NEWS
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV - MarketBeat
Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D - GuruFocus
West Pharmaceutical Services (WST) Receives a Buy from Barclays - The Globe and Mail
West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical lifts guidance on HVP-driven surge - The Globe and Mail
West Pharmaceutical Services, Inc. (WST) Earnings Dates, Call Summary & Reports - TipRanks
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance
West Pharmaceutical Services, Inc. (WPS) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Securities Class Action Lawsuit Filed Against West Pharmaceutical - The National Law Review
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and Thermo Fisher (TMO) - The Globe and Mail
West Pharmaceutical Services, Inc. (WPS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge - Quiver Quantitative
West Pharmaceutical Services Q2 2026 Earnings: Revenue, Net Income, and Financial Highlights - Minichart
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $410 - Moomoo
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook - Yahoo Finance
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating - marketscreener.com
West Pharmaceutical beats 2Q26 estimates, raises full-year sales and EPS guidance. - Pluang
West Pharmaceutical Delivers Another BeatBut The Real Story Is The Mix Shift (NYSE:WST) - Seeking Alpha
Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical: Q2 Earnings Snapshot - theheraldreview.com
West Pharmaceutical Earnings: Another Strong Quarter and Upward Guidance Revision - Morningstar
West Pharmaceutical Services Inc. Stock Slips 7.7%, Underperforms Peers - Bitget
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de
West Pharmaceutical Services, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:WST) 2026-07-24 - Seeking Alpha
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
West Pharmaceutical Services Inc Azioni (WST) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Option Exercise |
83.47 |
2,817 |
235,135 |
19,645 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Sale |
305.20 |
2,817 |
859,753 |
16,828 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Option Exercise |
173.22 |
896 |
155,205 |
2,419 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Sale |
300.67 |
896 |
269,399 |
1,523 |
2.09%
5.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):